Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Sell
46
RHHBY Quote, Financials, Valuation and Earnings
Last price:
$40.66
Seasonality move
:
3.79%
Day range:
$40.60 - $41.09
52-week range:
$29.20 - $44.31
Dividend yield:
3.35%
P/E ratio:
28.33x
P/S ratio:
3.73x
P/B ratio:
7.36x
Volume:
3.2M
Avg. volume:
3M
1-year change:
34.06%
Market cap:
$258.7B
Revenue:
$70.9B
EPS (TTM):
$1.44
Analysts' Opinion
-
Consensus RatingRoche Holding AG has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $45.92, Roche Holding AG has an estimated upside of 12.93% from its current price of $40.66.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $41.00 representing -0.84% downside risk from its current price of $40.66.
Fair Value
-
According to the consensus of 7 analysts, Roche Holding AG has 12.93% upside to fair value with a price target of $45.92 per share.
RHHBY vs. S&P 500
-
Over the past 5 trading days, Roche Holding AG has overperformed the S&P 500 by 2.88% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Roche Holding AG does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Roche Holding AG has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Roche Holding AG reported revenues of --.
Earnings Growth
-
Roche Holding AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Roche Holding AG reported earnings per share of --.
Enterprise value:
282.8B
EV / Invested capital:
--
Price / LTM sales:
3.73x
EV / EBIT:
19.20x
EV / Revenue:
4.04x
PEG ratio (5yr expected):
--
EV / Free cash flow:
16.65x
Price / Operating cash flow:
15.36x
Enterprise value / EBITDA:
15.22x
Gross Profit (TTM):
$51.7B
Return On Assets:
8.46%
Net Income Margin (TTM):
13.16%
Return On Equity:
23.8%
Return On Invested Capital:
12.15%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2024-04-30 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $37.7B | $39B | $36.5B | $39.8B | $44.3B | |
| Total Assets | $98.6B | $101B | $95.1B | $107.7B | $112.7B | |
| Current Liabilities | $29.1B | $42B | $29.4B | $29.6B | $29.9B | |
| Total Liabilities | $53.1B | $70B | $60.5B | $68.1B | $72.6B | |
| Total Equity | $45.5B | $31B | $34.5B | $39.6B | $40B | |
| Total Debt | $16.3B | $34.1B | $27.3B | $34.8B | $38.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2024-04-30 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
RHHBY
Sector
Market Cap
$258.7B
$34.4M
Price % of 52-Week High
91.76%
44.25%
Dividend Yield
3.35%
0%
Shareholder Yield
2.92%
-0.82%
1-Year Price Total Return
34.06%
-39.44%
Beta (5-Year)
0.479
0.738
Dividend yield:
3.35%
Annualized payout:
$1.35
Payout ratio:
91.76%
Growth streak:
5 years
Technicals
8-day SMA
Buy
Level
$39.53
200-day SMA
Buy
Level
$38.95
Bollinger Bands (100)
Buy
Level
36.06 - 41.74
Chaikin Money Flow
Buy
Level
206M
20-day SMA
Buy
Level
$38.68
Relative Strength Index (RSI14)
Buy
Level
57.04
ADX Line
Buy
Level
24.09
Williams %R
Sell
Level
-6.7823
50-day SMA
Sell
Level
$40.91
MACD (12, 26)
Sell
Level
-0.20
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
50.6M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.6577)
Sell
CA Score
(Annual)
Level (-0.4354)
Buy
Beneish M-Score
(Annual)
Level (-3.0502)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.9652)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
Stock Forecast FAQ
In the current month, RHHBY has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The RHHBY average analyst price target in the past 3 months is $45.92.
-
Where Will Roche Holding AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Roche Holding AG share price will rise to $45.92 per share over the next 12 months.
-
What Do Analysts Say About Roche Holding AG?
Analysts are divided on their view about Roche Holding AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Roche Holding AG is a Sell and believe this share price will drop from its current level to $41.00.
-
What Is Roche Holding AG's Price Target?
The price target for Roche Holding AG over the next 1-year time period is forecast to be $45.92 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.
-
Is RHHBY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Roche Holding AG is a Hold. 5 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of RHHBY?
You can purchase shares of Roche Holding AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Roche Holding AG shares.
-
What Is The Roche Holding AG Share Price Today?
Roche Holding AG was last trading at $40.66 per share. This represents the most recent stock quote for Roche Holding AG. Yesterday, Roche Holding AG closed at $40.66 per share.
-
How To Buy Roche Holding AG Stock Online?
In order to purchase Roche Holding AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is up 23.1% over the past day.
Sell
35
RGC alert for Apr 30
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 14.88% over the past day.
